European Regulators Reject Vivus Obesity Drug Used In US
The European Medicines Agency on Thursday rejected Vivus Inc.'s application for approval of its Qsiva weight-control drug for human use, citing concerns about the drug's long-term effects on patients' heart and...To view the full article, register now.
Already a subscriber? Click here to view full article